外周血管干预后吸烟跛行患者的长期结局
本研究利用多机构VISION数据库纳入2004至2019年因外周动脉闭塞性疾病行PVI的跛行患者18726例,经倾向性评分匹配比较非吸烟者、既往吸烟者与当前吸烟者的5年结局。既往吸烟者与非吸烟者的总生存、无再干预和截肢-free生存无显著差异;当前吸烟者较既往吸烟者总生存和无截肢生存更低。
要点
- 既往吸烟者与非吸烟者5年总生存无显著差异(HR 0.94,95%CI 0.82-1.09,P=.43)。
- 当前吸烟者较既往吸烟者5年总生存更低(HR 1.18,95%CI 1.04-1.33,P=.01)。
- 作者建议,择期PVI前应强烈鼓励并转介吸烟跛行患者参加结构化戒烟项目,或要求其戒烟。
核心结论
- 既往吸烟者与非吸烟者的5年总生存、无再干预和截肢-free生存相似;当前吸烟者较既往吸烟者总生存和无截肢生存更低。
研究设计与样本
- 多机构去标识Vascular Quality Initiative/Medicare联动数据库(VISION)研究,纳入2004至2019年因外周动脉闭塞性疾病行PVI的跛行患者18726例。
- 样本包括非吸烟者3617例(19.3%)、既往吸烟者9975例(53.3%)和当前吸烟者5134例(27.4%)。
- 对29个变量进行倾向性评分匹配,非吸烟者与既往吸烟者匹配后各3160对,既往吸烟者与当前吸烟者匹配后各3750对。
主要发现
- 既往吸烟者与非吸烟者总生存无显著差异(HR 0.94,95%CI 0.82-1.09,P=.43)。
- 既往吸烟者与非吸烟者无再干预无显著差异(HR 0.96,95%CI 0.89-1.04,P=.35)。
- 既往吸烟者与非吸烟者无截肢生存无显著差异(HR 0.90,95%CI 0.79-1.03,P=.12)。
- 既往吸烟者较当前吸烟者总生存更高(HR 1.18,95%CI 1.04-1.33,P=.01)。
- 既往吸烟者较当前吸烟者无再干预更优(HR 0.89,95%CI 0.83-0.96,P=.003)。
临床怎么用
- 作者认为,基于观察到的5年获益,应强烈鼓励吸烟跛行患者并转介至结构化戒烟项目,或要求其在择期PVI前戒烟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Emphasis on tobacco cessation, given the urgent and emergent nature of vascular surgery, is less prevalent than standard elective cases such as hernia repairs, cosmetic surgery, and bariatric procedures. The goal of this study is to determine the effect of active smoking on claudicating individuals undergoing peripheral vascular interventions (PVIs). Our goal is to determine if a greater emphasis on education should be placed on smoking cessation in nonurgent cases scheduled through clinic visits and not the Emergency Department. METHODS: This study was performed using the multi-institution de-identified Vascular Quality Initiative/Medicare-linked database (Vascular Implant Surveillance and Interventional Outcomes Network [VISION]). Claudicants who underwent PVI for peripheral arterial occlusive disease between 2004 and 2019 were included in our study. Our final sample consisted of a total of 18,726 patients: 3617 nonsmokers (19.3%) (NSs), 9975 former smokers (53.3%) (FSs), and 5134 current smokers (27.4%) (CSs). We performed propensity score matching on 29 variables (age, gender, race, ethnicity, treatment setting [outpatient or inpatient], obesity, insurance, hypertension, diabetes, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, previous coronary artery bypass graft, carotid endarterectomy, major amputation, inflow treatment, prior bypass or PVI, preoperative medications, level of treatment, concomitant endarterectomy, and treatment type [atherectomy, angioplasty, stent]) between NS vs FS and FS vs CS. Outcomes were long-term (5-year) overall survival (OS), limb salvage (LS), freedom from reintervention (FR), and amputation-free survival (AFS). RESULTS: Propensity score matching resulted in 3160 well-matched pairs of NS and FS and 3750 well-matched pairs of FS and CS. There was no difference between FS and NS in terms of OS (hazard ratio [HR], 0.94; 95% confidence interval [CI], 0.82-1.09; P = .43), FR (HR, 0.96; 95% CI, 0.89-1.04; P = .35), or AFS (HR, 0.90; 95% CI, 0.79-1.03; P = .12). However, when compared with CS, we found FS to have a higher OS (HR, 1.18; 95% CI, 1.04-1.33; P = .01), less FR (HR, 0.89; 95% CI, 0.83-0.96; P = .003), and greater AFS (HR, 1.16; 95% CI, 1.03-1.31; P = .01). CONCLUSIONS: This multi-institutional Medicare-linked study looking at elective PVI cases in patients with peripheral artery disease presenting with claudication found that FSs have similar 5-year outcomes in comparison to NSs in terms of OS, FR, and AFS. Additionally, CSs have lower OS and AFS when compared with FSs. Overall, this suggests that smoking claudicants should be highly encouraged and referred to structured smoking cessation programs or even required to stop smoking prior to elective PVI due to the perceived 5-year benefit.
引用
- Patel RJ, Zarrintan S, Vootukuru NR, et al. Long-term outcomes in the smoking claudicant after peripheral vascular interventions. J Vasc Surg. 2024. PMID: 38432487. doi:10.1016/j.jvs.2024.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。